Skip to main content
. 2014 Feb 15;16(9):814–822. doi: 10.1007/s12094-013-1153-7

Table 4.

Impact of chemotherapy delivery on disease-free survival

DFS Survival probability (%)
<2 cycles (n = 216) ≥2 cycles (n = 15) <15 days (n = 226) ≥15 days (n = 5) ≥85 % RDI (n = 226) <85 % RDI (n = 5) Overall % (95 % CI)
2 years 99 93 98 100 99 80 98 (97–100)
p 0.126 0.765 0.001*
4 years 91 93 91 100 91 80 91 (87–95)
p 0.791 0.491 0.315
5 years 88 93 88 100 88 80 88 (84–92)
p 0.562 0.418 0.500
6 years 86 93 86 100 87 80 87 (82–91)
p 0.473 0.375 0.563
8 years 84 93 85 100 85 80 84 (79–90)
p 0.465 0.366 0.621
10 years 79 93 79 100 80 80 80 (72–87)
p 0.418 0.323 0.695

CI confidence interval, DFS disease-free survival, RDI relative dose intensity

* Statistically significant